BR9808226A - Coronavìrus respiratório bovino como uma vacina - Google Patents
Coronavìrus respiratório bovino como uma vacinaInfo
- Publication number
- BR9808226A BR9808226A BR9808226A BR9808226A BR9808226A BR 9808226 A BR9808226 A BR 9808226A BR 9808226 A BR9808226 A BR 9808226A BR 9808226 A BR9808226 A BR 9808226A BR 9808226 A BR9808226 A BR 9808226A
- Authority
- BR
- Brazil
- Prior art keywords
- vaccine
- bovine respiratory
- respiratory coronavirus
- bovine
- coronavirus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Patente de Invenção: <B> "CORONAVìRUS RESPIRATóRIO BOVINO COMO UMA VACINA". <D> A presente invenção refere-se a um coronavírus respiratório bovino vivo modificado ou inativado e a coronaviroses entéricas bovinas e seus antígenos usados como uma vacina a fim de proteger contra doenças por coronavírus respiratório bovino e coronavírus entérico bovino e a processos para fabricação e uso dos mesmos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81431197A | 1997-03-10 | 1997-03-10 | |
PCT/US1998/004392 WO1998040097A2 (en) | 1997-03-10 | 1998-03-04 | Bovine respiratory and enteric coronavirus as a vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9808226A true BR9808226A (pt) | 2000-05-16 |
Family
ID=25214684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9808226A BR9808226A (pt) | 1997-03-10 | 1998-03-04 | Coronavìrus respiratório bovino como uma vacina |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0975360B1 (pt) |
JP (1) | JP2001519781A (pt) |
KR (1) | KR100531491B1 (pt) |
CN (1) | CN1283315C (pt) |
AT (1) | ATE334697T1 (pt) |
AU (1) | AU725439B2 (pt) |
BR (1) | BR9808226A (pt) |
CA (1) | CA2231591A1 (pt) |
DE (1) | DE69835424T2 (pt) |
DK (1) | DK0975360T3 (pt) |
ES (1) | ES2270508T3 (pt) |
NZ (1) | NZ337702A (pt) |
WO (1) | WO1998040097A2 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0000891D0 (en) * | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
CN100438908C (zh) * | 2001-10-06 | 2008-12-03 | 梅瑞尔有限公司 | CpG制剂及相关方法 |
US7375202B2 (en) * | 2003-03-24 | 2008-05-20 | The University Of Hong Kong | Human virus causing severe acute respiratory syndrome (SARS) and uses thereof |
WO2005005596A2 (en) * | 2003-06-18 | 2005-01-20 | Chinese National Human Genome Center At Shanghai | Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof |
CN1318580C (zh) * | 2003-07-10 | 2007-05-30 | 北京科兴生物制品有限公司 | 可满足灭活疫苗生产的sars病毒规模化制备及灭活的方法 |
WO2011056175A1 (en) | 2009-11-06 | 2011-05-12 | Intervet International B.V. | Methods of immunizing pregnant heifers at three months of gestation |
AU2015310932B2 (en) * | 2014-09-03 | 2018-11-22 | Intervet International B.V. | Attenuated bovine coronavirus and related vaccines |
CN111117975A (zh) * | 2020-01-03 | 2020-05-08 | 西南民族大学 | 牛冠状病毒he基因重组株及其制备的灭活疫苗和应用 |
CN113322241B (zh) * | 2021-05-14 | 2023-06-13 | 金宇保灵生物药品有限公司 | 一种牛副流感病毒3型病毒株bpiv3-nm及其应用 |
CN117286111B (zh) * | 2023-03-13 | 2024-06-18 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | 牛冠状病毒分离株、稳定表达牛冠状病毒n蛋白细胞系及在构建反向遗传操作系统中的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5580778A (en) * | 1994-06-15 | 1996-12-03 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Isolation and diagnosis of coronaviruses as a factor in bovine shipping fever, and a cell line for culturing both those and other bovine coronaviruses |
DK0833903T3 (da) * | 1995-06-12 | 2005-01-03 | Univ Kansas State | Multivalent vaccine mod bovint coronavirus og fremgangsmåde til behandling af infektioner forårsaget af bovint coronavirus |
-
1998
- 1998-03-04 WO PCT/US1998/004392 patent/WO1998040097A2/en active IP Right Grant
- 1998-03-04 BR BR9808226A patent/BR9808226A/pt not_active Application Discontinuation
- 1998-03-04 DE DE1998635424 patent/DE69835424T2/de not_active Expired - Fee Related
- 1998-03-04 KR KR10-1999-7007847A patent/KR100531491B1/ko not_active IP Right Cessation
- 1998-03-04 AU AU63465/98A patent/AU725439B2/en not_active Ceased
- 1998-03-04 EP EP98907727A patent/EP0975360B1/en not_active Expired - Lifetime
- 1998-03-04 NZ NZ337702A patent/NZ337702A/en unknown
- 1998-03-04 CN CNB988032457A patent/CN1283315C/zh not_active Expired - Fee Related
- 1998-03-04 DK DK98907727T patent/DK0975360T3/da active
- 1998-03-04 JP JP53963698A patent/JP2001519781A/ja not_active Withdrawn
- 1998-03-04 ES ES98907727T patent/ES2270508T3/es not_active Expired - Lifetime
- 1998-03-04 AT AT98907727T patent/ATE334697T1/de not_active IP Right Cessation
- 1998-03-09 CA CA 2231591 patent/CA2231591A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1998040097A3 (en) | 1999-01-14 |
AU6346598A (en) | 1998-09-29 |
DE69835424T2 (de) | 2007-02-08 |
CA2231591A1 (en) | 1998-09-10 |
ATE334697T1 (de) | 2006-08-15 |
WO1998040097A2 (en) | 1998-09-17 |
CN1250380A (zh) | 2000-04-12 |
KR100531491B1 (ko) | 2005-11-28 |
NZ337702A (en) | 2001-05-25 |
ES2270508T3 (es) | 2007-04-01 |
KR20000075775A (ko) | 2000-12-26 |
AU725439B2 (en) | 2000-10-12 |
CN1283315C (zh) | 2006-11-08 |
EP0975360A2 (en) | 2000-02-02 |
DE69835424D1 (de) | 2006-09-14 |
DK0975360T3 (da) | 2006-11-27 |
JP2001519781A (ja) | 2001-10-23 |
EP0975360B1 (en) | 2006-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200002855T2 (tr) | Raloksifenin solunum yolu ile veya burundan uygulanması. | |
DK0760848T3 (da) | Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf | |
NO991524L (no) | Vaksiner | |
CY1105963T1 (el) | Συνθεσεις καψομepιδιακου εμβολιου του ιου του θηλωματος και μεθοδοι χρησης | |
NO982497L (no) | Vaksine-sammensetninger for inntak gjennom nesen | |
ATE264691T1 (de) | Newcastle-krankheitsvirus-kombinationsimpfstoff | |
ES2167717T3 (es) | Nuevos aminoacidos ciclicos sustituidos como agentes farmaceuticos. | |
ES2089316T3 (es) | Agente viral asociado con la enfermedad porcina misteriosa (mystery swine desease). | |
DE60041761D1 (de) | Tribonektine | |
BR9808226A (pt) | Coronavìrus respiratório bovino como uma vacina | |
PT998287E (pt) | Utilizacao de levobupivacaina | |
HUP9901958A2 (hu) | Sertés reproduktív és respirációs szindróma vakcina | |
ATE345354T1 (de) | Methode zur identifizierung von helicobacter antigenen | |
HU0000362D0 (en) | Novel antigenic class of avian reoviruses | |
DE69738641D1 (de) | Lebend-impfstoff gegen heliobacter pylori | |
BR0002826A (pt) | Desfolhadeira mecânica | |
ES2162919T3 (es) | Piridilbisfosfonatos para uso como agente terapeutico. | |
BR0209145A (pt) | Vacina contra varìola | |
ES2184987T3 (es) | Formas de administracion solidas de liberacion instantanea y procedimiento para su preparacion. | |
ATE283066T1 (de) | Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp) | |
WO1999020305A8 (en) | Veterinary vaccines | |
ATE353226T1 (de) | Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form | |
BR9711138A (pt) | Prepara-{es de herperv¡rus equino com prote-Æo mÚtua e m-todo de fazer e usar as mesmas | |
PT796256E (pt) | Novos processos de preparacao da ranitidina | |
AP9801399A0 (en) | Zona pellucida proteins for contraception. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: O DEPOSITANTE DEIXOU DE APRESENTAR MANIFESTACAO SOBRE O PARECER NEGATIVO, ASSIM, DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR. |